| Literature DB >> 31470583 |
Xi-Xiang Tang1, Shun-Zhi Liu2, Xia Yan3, Bo-Wen Tang2, Mei-Juan Fang2, Xiu-Min Wang2, Zhen Wu4, Ying-Kun Qiu5.
Abstract
Penicillum citreonigrum XT20-134 (MCCC 3A00956) is a fungus with cytotoxic activity, derived from deep-sea sediment. Five new compounds, adeninylpyrenocine (1), 2-hydroxyl-3-pyrenocine-thio propanoic acid (2), ozazino-cyclo-(2,3-dihydroxyl-trp-tyr) (3), 5,5-dichloro-1-(3,5-dimethoxyphenyl)-1,4-dihydroxypentan-2-one (4), and 2,3,4-trihydroxybutyl cinnamate (5), together with 19 known compounds (6-24), were isolated from an ethyl acetate (EtOAc) extract of its fermentation. The structures of the new compounds were comprehensively characterized by high-resolution electrospray ionization-mass spectrometry (HR-ESI-MS), 1D and 2D nuclear magnetic resonance (NMR). All isolates were evaluated for their cytotoxic activities. The heteroatom-containing new compounds 2 and 4 showed potent cytotoxicity to the human hepatoma tumor cell Bel7402 with IC50 values of 7.63 ± 1.46, 13.14 ± 1.41 μM and the human fibrosarcoma tumor cell HT1080 with IC50 values of 10.22 ± 1.32, 16.53 ± 1.67 μM, respectively.Entities:
Keywords: MCCC 3A00956; Penicillum citreonigrum XT20-134; cytotoxic activity; deep-sea fungus
Year: 2019 PMID: 31470583 PMCID: PMC6780507 DOI: 10.3390/md17090509
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of compounds 1–24 isolated from an extract of Penicillum citreonigrum XT20-134.
Figure 2Key 1H–1H COSY, HMBC correlations of compounds 1–5.
Figure 3Calculated (9R and 9S) and experimental electronic circular dichroism (ECD) spectra of compound 1.
1H NMR and 13C NMR (DMSO-d6) data of compounds 1 and 2.
| Positions | 1 | 2 | 2’ | |||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| 2 | 162.0 | 162.2 | 162.2 | |||
| 3 | 87.8 | 5.62, s | 87.9 | 5.69, s | 87.9 | 5.69, s |
| 4 | 168.3 | 168.5 | 168.5 | |||
| 5 | 115.1 | 115.4 | 115.4 | |||
| 6 | 162.8 | 163.2 | 163.2 | |||
| 7 | 198.8 | 199.5 | 199.5 | |||
| 8 | 49.3 | 3.78, dd (17.6, 7.9) | 51.7 | 2.99, dd (17.1, 6.6) | 51.6 | 2.99, dd (17.1, 6.6) |
| 3.35, dd (17.6, 6.0) | 2.90, dd (17.1, 3.7) | 2.89, dd (17.1, 3.7) | ||||
| 9 | 47.7 | 5.06, m | 36.3 | 3.30, m | 36.2 | 3.30, m |
| 10 | 21.1 | 1.54, br. d (6.6) | 21.8 | 1.23, d (6.8) | 21.8 | 1.23, d (6.8) |
| 6-CH3 | 18.0 | 1.85, s | 18.5 | 2.18, d (2.6) | 18.5 | 2.18, d (2.6) |
| 4-OCH3 | 57.4 | 3.74, s | 57.5 | 3.87, s | 57.5 | 3.87, s |
| 2′ | 152.6 | 8.11, br. s | ||||
| 4′ | 149.5 | |||||
| 5′ | 119.5 | |||||
| 6′ | 156.4 | |||||
| 8′ | 140.3 | 8.21, br. s | ||||
| 6′-NH2 | 7.16, br. s | |||||
| 1′ | 174.5 | 174.5 | ||||
| 2′ | 71.1 | 4.09, m | 71.0 | 4.09, m | ||
| 3′ | 34.7 | 2.83, dd (13.5, 5.1) | 34.6 | 2.82, dd (13.5, 5.1) | ||
| 2.72, dd (13.6, 9.5) | 2.71, dd (13.6, 9.5) | |||||
Cytotoxic activities of compounds 2 and 4 (IC50, μM).
| Compd. | Bel7402 | HT1080 | Cne2 | A549 |
|---|---|---|---|---|
|
| 7.63 ± 1.46 | 10.22 ± 1.32 | 73.14 ± 5.32 | 87.08 ± 7.32 |
|
| 13.14 ± 1.41 | 16.53 ± 1.67 | 83.56 ± 6.49 | 92.47 ± 6/33 |
| paclitaxel | <1 | <1 | <1 | <1 |
| DMSO | None | None | None | None |
1H NMR and 13C NMR (DMSO-d6) data of compounds 3 and 19.
| Positions | 3 | 19 | ||
|---|---|---|---|---|
|
|
|
|
| |
| 2 | 99.3 | 5.10, d (2.8) | 121.4 | 6.88, br. s |
| 3 | 74.6 | 109.2 | ||
| 4 | 123.1 | 6.90, br. d (7.2) | 118.9 | 7.43, br. d (7.2) |
| 5 | 118.3 | 6.56, br. t (7.0) | 119.2 | 6.93, br. t (7.0) |
| 6 | 129.1 | 7.00, br. t (7.5) | 124.9 | 7.01, br. t (7.4) |
| 7 | 109.6 | 6.56, br. d (7.7) | 111.8 | 7.26, br. d (7.7) |
| 3a | 131.9 | 128.0 | ||
| 7a | 148.1 | 136.5 | ||
| 1′ | 136.0 | 137.0 | ||
| 2′, 6′ | 130.4 | 6.98, br. d (7.2) | 130.2 | 7.10, overlapped |
| 3′, 5′ | 128.2 | 6.86, br. t (7.4) | 128.5 | 6.64, br. t (7.4) |
| 4′ | 126.5 | 6.75, m | 126.9 | 7.12, overlapped |
| C=O | 166.1 | 166.7 | ||
| C=O′ | 161.5 | 167.3 | ||
| α | 54.6 | 4.17, dd (9.1, 4.8) | 55.8 | 3.92, m |
| α′ | 54.8 | 4.19, dd (5.0, 2.8) | 56.1 | 3.79, m |
| β′ | 37.7 | 2.87, dd (13.9, 2.8) | 39.5 | 2.40, overlapped |
| 2.74, dd (13.8, 5.0) | 1.78, dd (13.5, 7.0) | |||
| β | 36.0 | 1.91, dd (13.6, 4.8) | 30.2 | 2.74, dd (14.0, 4.4) |
| 1.03, dd (13.5, 9.1) | 2.44, overlapped | |||
| 1-NH | 6.57, br. s | 10.83, br. s | ||
| α-NH | 7.85, br. s | |||
| α′-NH | 7.96, br. s | 7.64, br. s | ||